Federal Data Hub › HRSA 340B · JSON
DEPARTMENT OF PEDIATRICS (D-820) · 340B ID HM33136
ParticipatingHemophilia Treatment Center
UNIVERSITY OF MIAMI - HEMOPHILIA AND THROMBOSIS COMPREHENSIVE TREATMENT CENTER is a Hemophilia Treatment Center enrolled in the federal 340B Drug Pricing Program in Miami, FL. The program lets qualifying providers buy outpatient drugs at deep federal discounts. This entity reports 6 contract-pharmacy arrangement(s) (1 currently active) — the third-party pharmacies that dispense its 340B-discounted drugs.
| Pharmacy | Location | Begin | Terminated | Pharmacy ID |
|---|---|---|---|---|
| FFP, LLC | PLANTATION, FL | 2022-01-01 | 2023-01-01 | 40693 |
| HEMOPHILIA OF FLORIDA PHARMACY, LLC | WINTER PARK, FL | 2013-10-01 | 2020-12-31 | 88023 |
| HEMOPHILIA OF GEORGIA | SANDY SPRINGS, GA | 2009-01-01 | — | 840 |
| LUX INFUSION 11 | GARNET VALLEY, PA | 2022-01-01 | 2023-01-01 | 26056 |
| LUX INFUSION 5 | BARTLETT, TN | 2022-01-01 | 2023-01-01 | 45972 |
| RED CHIP OF NEVADA | IRVINE, CA | 2022-01-01 | 2023-01-01 | 95592 |
Click a Pharmacy ID to see every other 340B entity using that same pharmacy.
The 340B Drug Pricing Program (Public Health Service Act §340B) requires drug manufacturers to sell outpatient drugs to enrolled "covered entities" — disproportionate-share hospitals, federally qualified health centers, and specialized clinics — at significant discounts. Covered entities increasingly contract with third-party "contract pharmacies" to dispense these drugs, a practice that has grown explosively and drawn scrutiny over how the discounts are used. This page mirrors HRSA's Office of Pharmacy Affairs (OPAIS) public registry.
Source: HRSA OPAIS. License: CC0 1.0. Snapshot 2026-06-25.